Takeda Pharmaceutical agrees to settlement in lawsuit related to the drug Actos

The New York Times reported today that Takeda Pharmaceutical announced this week that it has agreed to pay $2.4 billion to settle most of the product liability lawsuits related to the drug Actos, a diabetes drug. While the manufacturer continues to deny liability, the lawsuits alleges that Actos causes bladder cancer and has affected patients across the country including in the States of Ohio and Florida.

If you or a family member has been diagnosed with bladder cancer and have taken Actos, call the Robenalt Law Firm for a free consultation to determine if you're eligible to participate in the Takeda Actos settlement.

Categories: Product Liability

Free Confidential Consultation

  • This field is for validation purposes and should be left unchanged.

closeClose